INTEGRA announces $10 000 contribution to Boston’s Dana-Farber Cancer Institute

ntegra and Labotec support breast cancer research through sales of Pipetgirl pipette controllerFollowing the launch of its limited edition Pipetgirl pink pipette controller in support of breast cancer research earlier this year, Integra is pleased to announce it has made a $10 000 contribution to the Susan F. Smith Centre for Women’s Cancers at Dana-Farber Cancer Institute in Boston, USA. Labotec, as agents for Integra in Southern Africa, joined the campaign this year by donating R120 for every purchase of an Integra Pipetgirl in commitment to supporting breast cancer research. They are delighted that the first milestone has been reached.

Dana-Farber Cancer Institute, a principal teaching affiliate of Harvard Medical School, is world-renowned for its leadership in adult and paediatric cancer treatment and research. Designated as a comprehensive cancer centre by the National Cancer Institute (NCI), it is one of the largest recipients among independent hospitals of NCI and National Institutes of Health grant funding.

At the beginning of 2015, Integra decided to make Pipetgirl its symbol of its commitment to support breast cancer research.  The Pipetgirl pipette controller combines all the essential characteristics for productive work with serological pipettes – precision, speed, ease of use, lightweight operating comfort, long battery life and reliability. The Pipetgirl is designed for use with all commercially available glass and plastic serological pipettes in the volume range 1 – 100 ml. Each Pipetgirl pipette controller comes with a 3-year extended warranty to safeguard your investment.

To register your interest in supporting the global fight against breast cancer and to learn more about the Pipetgirl pipette, contact Labotec.

Labotec (Pty) Ltd

JHB: (011) 315 5434
CT: (021) 531 7660
DBN: (031) 566 4870
Fax: (011) 315 5882
[email protected]

Visit the official COVID-19 government website to stay informed: